GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivoryon Therapeutics NV (FRA:05Y) » Definitions » Deferred Policy Acquisition Costs

Vivoryon Therapeutics NV (FRA:05Y) Deferred Policy Acquisition Costs


View and export this data going back to 2014. Start your Free Trial

What is Vivoryon Therapeutics NV Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Vivoryon Therapeutics NV (FRA:05Y) Business Description

Industry
Traded in Other Exchanges
Address
Weinbergweg 22, Halle, SN, DEU, 06120
Vivoryon Therapeutics NV is a Germany-based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products include PQ912 and PQ1565. Geographically, the majority is from Greater China.